ES2529568T3 - Uso de cuerpos moldeados para aplicación externa - Google Patents

Uso de cuerpos moldeados para aplicación externa Download PDF

Info

Publication number
ES2529568T3
ES2529568T3 ES03808702.9T ES03808702T ES2529568T3 ES 2529568 T3 ES2529568 T3 ES 2529568T3 ES 03808702 T ES03808702 T ES 03808702T ES 2529568 T3 ES2529568 T3 ES 2529568T3
Authority
ES
Spain
Prior art keywords
external application
molded bodies
pharmeu
sphere
capsules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03808702.9T
Other languages
English (en)
Inventor
Stefan Frahling
Ralf Malessa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medskin Solutions Dr Suwelack AG
Original Assignee
Medskin Solutions Dr Suwelack AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2002148314 external-priority patent/DE10248314A1/de
Priority claimed from DE2003117982 external-priority patent/DE10317982A1/de
Application filed by Medskin Solutions Dr Suwelack AG filed Critical Medskin Solutions Dr Suwelack AG
Application granted granted Critical
Publication of ES2529568T3 publication Critical patent/ES2529568T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04—Alginic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Anesthesiology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Cuerpo moldeado liofilizado para aplicación externa, que contiene al menos un formador de estructura, exceptuándose proteínas, dado el caso uno o varios principios activos así como dado el caso una o varias sustancias auxiliares, que se caracteriza por que presenta la forma geométrica de una esfera con un diámetro de al menos 5 mm y una velocidad de solución de menos de 1 minuto, de manera correspondiente al método de medición del "tiempo de disgregación de comprimidos y cápsulas" por medio de los aparatos de ensayo de PharmEU.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8

Claims (1)

  1. imagen1
    imagen2
ES03808702.9T 2002-10-16 2003-09-30 Uso de cuerpos moldeados para aplicación externa Expired - Lifetime ES2529568T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE2002148314 DE10248314A1 (de) 2002-10-16 2002-10-16 Verwendung von Formkörpern zur äußeren Anwendung
DE10248314 2002-10-16
DE10317982 2003-04-17
DE2003117982 DE10317982A1 (de) 2003-04-17 2003-04-17 Verwendung von Formkörpern zur äußeren Anwendung
PCT/EP2003/010853 WO2004035023A1 (de) 2002-10-16 2003-09-30 Verwendung von formkörpern zur äusseren anwendung

Publications (1)

Publication Number Publication Date
ES2529568T3 true ES2529568T3 (es) 2015-02-23

Family

ID=32108791

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03808702.9T Expired - Lifetime ES2529568T3 (es) 2002-10-16 2003-09-30 Uso de cuerpos moldeados para aplicación externa

Country Status (7)

Country Link
US (1) US9023333B2 (es)
EP (1) EP1551373B1 (es)
JP (5) JP2006504799A (es)
AU (1) AU2003276011A1 (es)
ES (1) ES2529568T3 (es)
TW (1) TWI262796B (es)
WO (1) WO2004035023A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006038629A1 (de) * 2006-08-17 2008-02-21 Dr. Suwelack Skin & Health Care Ag Stabilisierte Wirkstoffzusammensetzung
US9125825B2 (en) 2009-04-22 2015-09-08 Medskin Solutions Dr. Suwelack Ag Freeze-dried molded article containing magnesium ascorbyl phosphate
CN101919806A (zh) * 2009-04-22 2010-12-22 苏维拉克皮肤及健康护理公司 活性物质的冻干组合物
BRPI1001091A2 (pt) * 2009-04-22 2011-03-22 Dr Suwelack Skin & Health Care Ag artigo moldado revestido secado por congelamento
GB2561818B (en) * 2017-03-30 2020-01-15 Phyto Sophos Ltd Plant extract compositions
CA3193396A1 (en) 2020-09-22 2022-03-31 Cory G. Miller Chitosan-containing coating compositions
CN115670941B (zh) * 2021-07-23 2025-04-04 嘉药学校财团法人嘉南药理大学 机能性悬浮造型晶球及其制造方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53696B1 (en) 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
JPS59108045A (ja) 1982-12-11 1984-06-22 Daicel Chem Ind Ltd カルボキシメチルセルロ−スゲル組成物およびその製法
JPS6122006A (ja) 1984-07-09 1986-01-30 Kanebo Ltd 球状粉末メイクアップ化粧料の製造方法
IT1219663B (it) 1988-06-20 1990-05-24 Agrofil Coop Sarl Procedimento per la preparazione di un prodotto alimentare in forma solida,a base di yogurt e/o latte e/o frutta liofilizzati,e relativo prodotto cosi' ottenuto
WO1990000391A1 (de) 1988-07-13 1990-01-25 Knoll Aktiengesellschaft Arzneimittel-depotform auf alginatbasis
FR2634376B1 (fr) 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
DE3832929C1 (es) 1988-09-28 1989-08-24 Voest-Alpine Automotive Ges.M.B.H., Linz, At
JPH02196795A (ja) 1989-01-25 1990-08-03 Nitto Denko Corp 新規配糖体および該配糖体を用いてなる徐放性芳香剤
FR2645439B1 (fr) * 1989-04-07 1991-06-21 Oreal Procede de preparation de capsules d'alginate(s) particulierement adaptees a un usage cosmetique, appareil pour sa mise en oeuvre et composition cosmetique contenant lesdites capsules
JP2865320B2 (ja) * 1989-08-07 1999-03-08 株式会社資生堂 固型化粧料組成物
DE4028622C2 (de) 1990-09-08 1994-01-27 Suwelack Nachf Dr Otto Verfahren zum Herstellen von Kollagenschwämmen
US5578307A (en) * 1992-01-17 1996-11-26 Alfatec-Pharma Gmbh Shaped articles containing plant extract(s), in particular pellets, and their pharmaceutical or cosmetic use
DE4201172C1 (en) 1992-01-17 1993-07-22 Alfatec-Pharma Gmbh, 6900 Heidelberg, De Pellets contg. Aloe vera extract - useful, e.g. as antiinflammatory of antibiotic agents, or for treating gastric ulcers
DE4201173C2 (de) 1992-01-17 1998-10-29 Alfatec Pharma Gmbh Akutarzneimittel in Form von Dihydropyridinderivaten enthaltenden Pellets und ihre Herstellung
ATE151631T1 (de) 1992-01-17 1997-05-15 Alfatec Pharma Gmbh Pflanzenwirkstoffextrakt enthaltende kryopelletierte formkörper und ihre pharmazeutische oder kosmetische verwendung
DE59309678D1 (de) * 1992-01-17 1999-08-05 Alfatec Pharma Gmbh Verfahren zur Herstellung von Wirkstoff enthaltenden Pulvern, Granulaten oder Pellets mit einem Gerüst aus hydrophilen Makromolekülen und ihre Verwendung
DE4201179A1 (de) 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
DE4328329C2 (de) 1992-08-26 1998-02-12 Suwelack Nachf Dr Otto Gefriergetrocknete Biomatrix
KR960016200B1 (ko) * 1993-07-09 1996-12-06 한국화장품 주식회사 화장용 스펀지팩 및 그 제조방법
DE19503465A1 (de) 1995-02-03 1996-08-08 Henkel Kgaa Verfahren zur Herstellung von niedrigviskosen kationischen Biopolymeren
JPH08325133A (ja) * 1995-05-26 1996-12-10 Tokuyasu:Kk 洗浄保湿剤
JP3108019B2 (ja) 1996-07-11 2000-11-13 第一工業製薬株式会社 歯磨き用粘結剤およびそれを用いた歯磨き
WO1998007403A1 (en) * 1996-08-21 1998-02-26 Kao Corporation Cosmetological methods
FR2764505B1 (fr) 1997-06-13 1999-10-15 Alain Dogliani Nouvelles compositions cosmetiques a base de lyophilisats d'alginates alcalins et nouveaux vecteurs de penetration
JP4017789B2 (ja) 1999-08-09 2007-12-05 クラシエホームプロダクツ株式会社 皮膚洗浄料
US6497887B1 (en) * 2000-04-13 2002-12-24 Color Access, Inc. Membrane delivery system
FR2808195B1 (fr) * 2000-04-28 2006-12-08 Lyophilisation Alimentaire Patch cosmetique ou dermatologique lyophilise
JP2002194367A (ja) * 2000-10-16 2002-07-10 Minoru Kojima 潤滑用固形品及びその製造方法
JP2002275048A (ja) 2001-03-21 2002-09-25 Pola Chem Ind Inc シャワー用のボディー・リンス

Also Published As

Publication number Publication date
US9023333B2 (en) 2015-05-05
WO2004035023A1 (de) 2004-04-29
JP2018002746A (ja) 2018-01-11
JP2013173780A (ja) 2013-09-05
JP5952774B2 (ja) 2016-07-13
EP1551373A1 (de) 2005-07-13
US20050281849A1 (en) 2005-12-22
AU2003276011A1 (en) 2004-05-04
TWI262796B (en) 2006-10-01
JP2016041759A (ja) 2016-03-31
JP2010280704A (ja) 2010-12-16
TW200413023A (en) 2004-08-01
JP2006504799A (ja) 2006-02-09
WO2004035023A8 (de) 2004-06-03
EP1551373B1 (de) 2014-11-12

Similar Documents

Publication Publication Date Title
ES2529092T3 (es) Método de prueba de analitos y el sistema de notificación de tendencias de la glucosa en sangre alta y baja
ES2524320T3 (es) Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo
ES2502472T3 (es) Composición adhesiva para su uso en un inmunosensor
ES2483725T3 (es) Composición básica cosmética y su uso
ES2661081T3 (es) Reactivo de liberación para compuestos de vitamina D
ES2421516T3 (es) Composiciones para tratar el cáncer usando el inhibidor de proteasomas PS-341
AR106702A2 (es) Uso de un anticuerpo antagonista anti-ngf para la preparación de un medicamento
BRPI0707612B8 (pt) vaso lacrado e formulações líquidas contidas no mesmo
ES2529568T3 (es) Uso de cuerpos moldeados para aplicación externa
ECSP055738A (es) PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL
AR073709A1 (es) Unidades de dosis de acido 3-(6-(1-(2,2-difluorobenzeno (d) (1,3) dioxol-5-il) ciclopropancarboxamido)-3-metilpiridin-2-il) benzoico
AR073452A1 (es) Proteinas de fusion que comprende dos o mas antigenos de leishmania y su uso en el diagnostico y tratamiento de leishmaniasis
CL2008002687A1 (es) Uso de una combinacion farmaceutica de un compuesto derivado de tieno[3,2-d]pirimidina con un agente quimioterapeutico en el tratamiento de un trastorno hiperproliferativo; kit farmaceutico.
BRPI1007945C1 (pt) composição farmacêutica, comprimido, e, usos de nitazoxanida ou de um seu análogo
CR10349A (es) Tabletas de paracetamol de liberacion rapida
NI200800193A (es) Anticuerpos humanos anti-il-23, composiciones, métodos y usos.
AR032524A1 (es) Composicion farmaceutica para capsulas moldeadas; composicion farmaceutica para envueltas de capsulas moldeadas; envuelta, elemento de union o separador de capsula moldeados por inyeccion con las mismas; forma de dosificacion farmaceutica de varios componentes y conjunto de formas de dosificacion de
ECSP088490A (es) Forma farmacéutica oral que contiene como principios activos un inhibidor de la bomba de protones junto con ácido acetilsalicílico
MX2007004079A (es) Detecci??n de niveles elevados de prote??na her-2/neu en celulas cancerosas circulantes y tratamiento.
MX337422B (es) Composiciones y metodos para incrementar la sencibilidad a la insulina.
UY29395A1 (es) Formulación de medicamentos conteniendo vardenafilo.
TR201904884T4 (tr) Koloni̇k boşaltmada kullanima yöneli̇k formülasyonlar ve formülasyonlarin üreti̇m yöntemleri̇
CL2015003596A1 (es) Formulación de liberación modificada
ES2494915T3 (es) P53 natural como biomarcador para el tratamiento con inhibidores de mTOR en combinación con un agente citotóxico
ES2526094T3 (es) Procedimiento para estabilizar formas de administración farmacéuticas que contienen microorganismos